CECOG Academy Podcasts

What is genetic consenting?

Why is genetic consenting important?

How is genetic consenting performed?

What is mainstream genetic consenting?

The importance of mainstream cpnsenting

Knowledge of genetics required by healthcare professionals prior to mainstream consenting

Practical approach to mainstream consenting

mainstream BRCA genetics: Learnings from an oncogenetic pathway

Alternative models for genetic consenting

Telegenetics model

Group consenting model

eHealth model

Future approaches to BRCA testing - investigations into app-based testing

Zoom in for HER2+ space: Pharmacology & clinical (efficacy and safety) for trastuzumab deruxtecan Later lines of treatment Host: Doz. Dr. Christiane Thallinger Univ. Prof. Dr. Evandro De Azambuja Institut Jules Bordet Belgium Univ. Prof. Dr. Christoph Zielinski Professor of Medical Oncology and Clinical Immunology Medical Director, Wiener Privatklinik and Central European Cancer Center Wien, A...

Targeted treatment options to improve outcomes in EGFRm NSCLC Host: Doz. Dr. Christiane Thallinger Univ. Prof Dr. Martin Filipits Institute of Cancer Research Department of Medicine I Medical University of Vienna Univ. Prof. Dr Bojan Zaric Institute for Pulmonary Diseases of Vojvodina Faculty of Medicine University of Novi Sad, Serbia

How new treatments are impacting the work of Multidisciplinary Teams (MTD) (incl guidelines discussion) Host: Doz. Dr. Christiane Thallinger Speakers: Dr. Mila Petrova MHAT Nadezhda Sofia, Bulgaria Univ. Prof. Dr. Christoph Zielinski Professor of Medical Oncology and Clinical Immunology Medical Director, Wiener Privatklinik and Central European Cancer Center Wien, Austria President, Central Europe...

Clinical implementation of immuno-oncology therapy in unresectable stage III NSCLC Host: Doz. Dr. Christiane Thallinger Univ. Prof. Dr. Tanja Cufer University Clinic Golnik Medical Faculty Ljubljana Slovenia Univ. Prof. Dr. Rafal Dziadziusko Department of Oncology and Radiotherapy Medical University of Gdansk

Changing the ES-SCLC Paradigm with Immuno-Oncology Combinations Host: Doz. Dr. Christiane Thallinger Speakers: Univ. Prof. Dr. Marko Jakopovic Thoracic Oncology Unit  Department for Respiratory Diseases University Hospital Centre Zagreb, Croatia Univ Prof Dr. Wolfgang Köstler  Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Austria

Patient needs in later lines of mBC (testing, efficacy of current treatment – what do we need) Host: Doz. Dr. Christiane Thallinger Univ. Prof. Dr. Rupert Bartsch Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Austria Dr. Alexandru Eniu, MD, PhD HÔPITAL RIVIERA-CHABLAIS, VAUD-VALAIS, Spécialiste FMH en oncologie médicale Médecin chef - Responsable Breast Uni...

PANCREAS CANCER ACADEMY 2020 - Panel discussion:  Advocates only

Panel discussion:  How COVID-19 affects Pancreas Cancer Patients

CECOG Offers TIGER and LEOPARD Virtual Transborder Tumour Boards to Deliver Optimal Cancer Care and Precision Medicine.

In this podcast, the president of CECGO, Prof. Christoph Zielinski, describes the problems and shortcomings of cancer care in Central and Southeastern Europe, as compared to the Western part of the contiinent and describes ways to overcome the deficits by reduction of systemic health inequalities and improvement of access to cancer care by focussing on prevention, screening, early diagnosis, and a...

CECOG - "Who we are and what we do" by CECOG President Christoph Zielinski